MétaCan
Menu
Back to cohort
Record W4409737607 · doi:10.1159/000546001

Middle Meningeal Artery Embolization in the Treatment of Chronic Subdural Hematoma: A Systematic Review and Meta-Analysis

2025· review· en· W4409737607 on OpenAlexaboutno aff
Shitai Ye, Sixi Zhang, Tianfang Li, Shuchao Wang, Xin Wang, Yong Deng, Longyang Yu, Qi Li, Xinggang Feng, Bingwu Jiang, Zhao Dai, Qifeng Guo, Qin Han, Wei Jin, Shunfu Jiang, Zhongming Qiu, Mohamad Abdalkader, Thanh N. Nguyen

Bibliographic record

VenueCerebrovascular Diseases · 2025
Typereview
Languageen
FieldMedicine
TopicNeurosurgical Procedures and Complications
Canadian institutionsnot available
Fundersnot available
KeywordsMedicineCochrane LibraryMeta-analysisRandomized controlled trialHematomaRelative riskMiddle meningeal arteryCohort studyInternal medicineObservational studySurgeryEmbolizationConfidence interval

Abstract

fetched live from OpenAlex

INTRODUCTION: There is increasing evidence that middle meningeal artery embolization (MMAE) can be used to treat chronic subdural hematoma (cSDH). The purpose of this study was to demonstrate the efficacy and safety of MMAE treatment through a systematic review and meta-analysis of observational studies and randomized controlled trials (RCTs). METHODS: We searched the PubMed, Embase, Cochrane Library, and Web of Science databases to obtain articles related to MMAE from inception to December 3, 2024. The effectiveness outcomes were recurrence, progression, or reoperation of subdural hematoma after treatment, 90-day mRS 0-2, and 90-day mRS 0-3. The safety outcomes were severe deterioration of neurologic function and death within 180 days. The quality of the RCTs was evaluated with the Cochrane risk assessment tool, while the cohort studies were evaluated by the Newcastle-Ottawa Scale (NOS). The random-effect model was used to calculate the effect as risk ratio (RR). The heterogeneity of the results of each study was analyzed by χ2 test. RESULTS: A total of 892 articles are retrieved. Among those, 4 RCTs and 5 cohort studies met the inclusion criteria. The RCT analysis showed that MMAE plus traditional treatment reduced the risk of recurrence or progression of hematoma compared with traditional treatment alone (5.3% vs. 9.1%; RR: 0.58, 95% CI, 0.39-0.86, p = 0.03). The heterogeneity was very low (I2 = 22%). There was no significant difference between the two groups for the 90-day mRS 0-2 and 0-3 scores (p = 0.73/p = 0.71, respectively). In terms of safety outcomes, the 180-day mortality was 3.5% in the MMAE plus traditional treatment group and 5.0% in the traditional treatment group (p = 0.49 > 0.05). Neurological deterioration was present in 4.6% of patients with MMAE plus traditional treatment compared to 3.9% with traditional treatment (p = 0.44 > 0.05). Across the 5 cohort studies, similar results were obtained for the incidence of recurrence, progression or reoperation of subdural hematoma (12.9% vs. 40.6%; RR: 0.26, 95% CI, 0.07-0.95, p = 0.04), but the heterogeneity was very high (I2 = 89%). CONCLUSION: This systematic review and meta-analysis showed that in cSDH patients, MMAE was associated with a reduced rate of recurrence, progression or reoperation of the subdural hematoma compared to traditional treatment with surgery without increasing the incidence of death or adverse events.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.000
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Meta-analysis · Consensus signal: none
GenreCandidate signal: Review · Consensus signal: Review
Teacher disagreement score0.904
Threshold uncertainty score0.732

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0000.000
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0060.004
Bibliometrics0.0000.001
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0000.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.067
GPT teacher head0.339
Teacher spread0.272 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designMeta-analysis
Domainnot available
GenreReview

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations11
Published2025
Admission routes1
Has abstractyes

Explore more

Same venueCerebrovascular DiseasesSame topicNeurosurgical Procedures and ComplicationsFrench-language works237,207